Brown, J E <br/><br/>
The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone disease.  [electronic resource] 

 -  Calcified tissue international  Nov 2007 
 - 341-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0171-967X 
<br/><br/><label>Standard No.: </label>10.1007/s00223-007-9061-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Alkaline Phosphatase--analysis<br/>Biomarkers--analysis<br/>Bone Density Conservation Agents--administration & dosage<br/>Bone Neoplasms--complications<br/>Bone Resorption--drug therapy<br/>Bone and Bones--drug effects<br/>Breast Neoplasms--pathology<br/>Calcium--analysis<br/>Clodronic Acid--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Peptide Fragments--analysis<br/>Placebos<br/>Predictive Value of Tests<br/>Procollagen--analysis<br/>Prostatic Neoplasms--pathology<br/>Sensitivity and Specificity<br/>Treatment Outcome